These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12661390)

  • 1. Managing genital chlamydia trachomatis infection in Scotland: targeted opportunistic testing or a screening programme?
    Clutterbuck DJ
    Health Bull (Edinb); 2001 Nov; 59(6):396-404. PubMed ID: 12661390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the impact of a national health demonstration project on testing and management for Chlamydia trachomatis infections in two regions of Scotland.
    Penney GC; Brace V; Cameron S; Tucker J
    Public Health; 2005 Nov; 119(11):1031-8. PubMed ID: 16084540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Coutinho RA; Jager JC
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):677-81. PubMed ID: 10321301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].
    Postma MJ; Welte R; van den Hoek JA; Jager JC; van Doornum GJ; Coutinho RA
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2383-5. PubMed ID: 10590778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prediction rule for selective screening of Chlamydia trachomatis infection.
    Götz HM; van Bergen JE; Veldhuijzen IK; Broer J; Hoebe CJ; Steyerberg EW; Coenen AJ; de Groot F; Verhooren MJ; van Schaik DT; Richardus JH
    Sex Transm Infect; 2005 Feb; 81(1):24-30. PubMed ID: 15681717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we evaluate population screening strategies in UK general practice? A pilot randomised controlled trial comparing postal and opportunistic screening for genital chlamydial infection.
    Senok A; Wilson P; Reid M; Scoular A; Craig N; McConnachie A; Fitzpatrick B; MacDonald A
    J Epidemiol Community Health; 2005 Mar; 59(3):198-204. PubMed ID: 15709078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the impact of opportunistic screening on the sequelae and public healthcare costs of infection with Chlamydia trachomatis in Australian women.
    Ward B; Rodger AJ; Jackson TJ
    Public Health; 2006 Jan; 120(1):42-9. PubMed ID: 16271271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Chlamydia trachomatis infection in small rural town family planning clinics in the central belt of Scotland.
    Sudlow E; Court S; Smith C
    Health Bull (Edinb); 2001 Sep; 59(5):332-4. PubMed ID: 12664747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for Chlamydia trachomatis infection: which group should be targeted and at what price?].
    van Vloten WA
    Ned Tijdschr Geneeskd; 1999 Mar; 143(13):652-3. PubMed ID: 10321294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The English National Chlamydia Screening Programme: variations in positivity in 2007/2008.
    Simms I; Talebi A; Rhia J; Horner P; French RS; Sarah R; Macintosh M
    Sex Transm Dis; 2009 Aug; 36(8):522-7. PubMed ID: 19455079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-infection of Chlamydia trachomatis in patients presenting to the genitourinary medicine clinic in Portsmouth: the chlamydia screening pilot study - three years on.
    Lee VF; Tobin JM; Harindra V
    Int J STD AIDS; 2004 Nov; 15(11):744-6. PubMed ID: 15537461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of Chlamydia trachomatis testing and chlamydial infection in pregnant women.
    Lawton B; Rose S; Bromhead C; Brown S; MacDonald J; Shepherd J
    N Z Med J; 2004 May; 117(1194):U889. PubMed ID: 15156207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands.
    van Bergen J; Götz HM; Richardus JH; Hoebe CJ; Broer J; Coenen AJ;
    Sex Transm Infect; 2005 Feb; 81(1):17-23. PubMed ID: 15681716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?
    Gottlieb SL; Berman SM; Low N
    J Infect Dis; 2010 Jun; 201 Suppl 2():S156-67. PubMed ID: 20470051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening.
    LaMontagne DS; Fenton KA; Randall S; Anderson S; Carter P
    Sex Transm Infect; 2004 Oct; 80(5):335-41. PubMed ID: 15459399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
    Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potentials of screening for Chlamydia trachomatis in Hungary: cost-benefit analysis].
    Nyári T; Mészáros G; Deák J; Nagy E; Kovács L
    Orv Hetil; 2000 Jul; 141(27):1511-6. PubMed ID: 10943109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia screening in a rural population: access, outcomes and health-care planning.
    Bendall RP; Keane FE; Barlow MJ; Paynter SJ
    Int J STD AIDS; 2007 Feb; 18(2):89-92. PubMed ID: 17331278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.